Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer
- PMID: 38349439
- DOI: 10.1007/s10528-024-10728-2
Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer
Abstract
SUMOylation, an important post-translational protein modification, plays a critical role in cancer development and immune processes. This study aimed to construct diagnostic and prognostic models for cervical cancer (CC) using SUMOylation-related genes (SRGs) and explore their implications for novel clinical therapies. We analyzed the expression profiles of SRGs in CC patients and identified 15 SRGs associated with CC occurrence. After the subsequent qPCR verification of 20 cases of cancer and adjacent tissues, 13 of the 15 SRGs were differentially expressed in cancer tissues. Additionally, we identified molecular markers associated with the prognosis and recurrence of CC patients, based on SRGs. Next, a SUMOScore, based on SRG expression patterns, was generated to stratify patients into different subgroups. The SUMOScore showed significant associations with the tumor microenvironment, immune function features, immune checkpoint expression, and immune evasion score in CC patients, highlighting the strong connection between SUMOylation factors and immune processes. In terms of immune therapy, our analysis identified specific chemotherapy drugs with higher sensitivity in the subgroups characterized by high and low SUMOScore, indicating potential treatment options. Furthermore, we conducted drug sensitivity analysis to evaluate the response of different patient subgroups to conventional chemotherapy drugs. Our findings revealed enrichment of immune-related pathways in the low-risk subgroup identified by the prognostic model. In conclusion, this study presents diagnostic and prognostic models based on SRGs, accompanied by a comprehensive index derived from SRGs expression patterns. These findings offer valuable insights for CC diagnosis, prognosis, treatment, and immune-related analysis.
Keywords: Cervical Cancer; Immune; Machine Learning; Prognosis; SUMOylation.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: All authors report no conflict of interest. Ethics Approval: The study was conducted according to guidelines approved by the Institutional Review Board of Southeast University. All participants signed informed consent. The approval number is 2018ZDKYSB022. Consent to Participate: Informed consent was obtained from each participant within the scope of this study. Consent to Publish: The authors affirm that human research participants provided informed consent for publication of the images in Fig. 2 and Table S2.
Similar articles
-
Identification of immune-related cervical cancer prognostic biomarkers and construction of prognostic model based on tumor microenvironment.Eur J Med Res. 2025 Apr 9;30(1):261. doi: 10.1186/s40001-025-02515-5. Eur J Med Res. 2025. PMID: 40205481 Free PMC article.
-
Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer.PeerJ. 2025 May 22;13:e19422. doi: 10.7717/peerj.19422. eCollection 2025. PeerJ. 2025. PMID: 40416607 Free PMC article.
-
The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment.Int J Mol Sci. 2023 Sep 2;24(17):13603. doi: 10.3390/ijms241713603. Int J Mol Sci. 2023. PMID: 37686409 Free PMC article.
-
Ferroptosis-related gene transferrin receptor protein 1 expression correlates with the prognosis and tumor immune microenvironment in cervical cancer.PeerJ. 2024 Aug 6;12:e17842. doi: 10.7717/peerj.17842. eCollection 2024. PeerJ. 2024. PMID: 39131609 Free PMC article.
-
Omics sciences for cervical cancer precision medicine from the perspective of the tumor immune microenvironment.Oncol Res. 2025 Mar 19;33(4):821-836. doi: 10.32604/or.2024.053772. eCollection 2025. Oncol Res. 2025. PMID: 40191729 Free PMC article. Review.
Cited by
-
Transcriptional and post-transcriptional regulation of CARMN and its anti-tumor function in cervical cancer through autophagic flux blockade and MAPK cascade inhibition.J Exp Clin Cancer Res. 2024 Nov 19;43(1):305. doi: 10.1186/s13046-024-03229-y. J Exp Clin Cancer Res. 2024. PMID: 39558374 Free PMC article.
References
-
- Cao Y, Huang C, Zhao X, Yu J (2023) Regulation of SUMOylation on RNA metabolism in cancers. Front Mol Biosci 10:1137215. https://doi.org/10.3389/fmolb.2023.1137215 - DOI - PubMed - PMC
-
- Cervical Cancer Analysis Reveals New Mutations (2017) Cancer Discov 7(4):344. https://doi.org/10.1158/2159-8290.CD-NB2017-020 - DOI
-
- Chen Y (2023) A new immuno-oncology target - SUMOylation. Trends Cancer. https://doi.org/10.1016/j.trecan.2023.04.010 - DOI - PubMed - PMC
-
- Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, Lin T (2021a) SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J Clin Invest 131(8). https://doi.org/10.1172/JCI146431
-
- Chen Y, Gu Y, Gu Y, Wu J (2021b) Long noncoding RNA LINC00899/miR-944/ESR1 Axis regulates cervical Cancer Cell Proliferation, Migration, and Invasion. J Interferon Cytokine Res 41(6):220–233. https://doi.org/10.1089/jir.2021.0023 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- KYCX21_0162/Postgraduate Research & Practice Innovation Program of Jiangsu Province
- KYCX22_0301/Postgraduate Research & Practice Innovation Program of Jiangsu Province
- JKA202202/Major Project of Jiangsu Health Vocational College
- ZZZC2022016/the Fundamental Research Funds for Shihezi University School of Medicine
- 2242023K40023/Fundamental Research Funds for the Central Universities
- JSHD2022056/Opening Foundation of Jiangsu Provincial Health Development Research Center
- Z2019009/Scientific research project of Jiangsu Provincial Health Commission
- 22KJB330004/Natural Science Foundation for Colleges and Universities of Jiangsu Province
- ZD2021030/Key Scientific Research Projects of Jiangsu Provincial Health Commission